TerrAscend grants CFO 300,000 stock options

TerrAscend Corp. granted its Chief Financial Officer, Eric Matthew Jackson, stock options covering 300,000 common shares.

Rhea-AI Filing Summary

TerrAscend Corp. granted its Chief Financial Officer, Eric Matthew Jackson, stock options covering 300,000 common shares. The options have an exercise price of $0.76 per share and expire on April 27, 2036. They vest in four equal annual installments beginning on the first anniversary of the grant date, aligning compensation with longer-term company performance.

Insider Trade Summary

Grant/Award: 300,000 shares

Grant/Award 1 txn

Insider Jackson Eric Matthew

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	300,000	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 300,000 contracts (Direct)

Footnotes (1)

1. F1. The option vests in four equal annual installments beginning on the first anniversary of the grant date.

Key Figures

Options granted: 300,000 options Exercise price: $0.76 per share Expiration date: April 27, 2036 +2 more

5 metrics

Options granted 300,000 options Grant to CFO on equity award date

Exercise price $0.76 per share Stock option strike price

Expiration date April 27, 2036 Option term end

Underlying shares 300,000 common shares Shares issuable upon exercise

Post-grant derivative holdings 300,000 options Total options held following transaction

Key Terms

Stock Option (right to buy), exercise price, expiration date, vesting, +1 more

5 terms

Stock Option (right to buy) financial

"security_title: Stock Option (right to buy)"

exercise price financial

"conversion_or_exercise_price: 0.7600 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: 2036-04-27"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

vesting financial

"The option vests in four equal annual installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

underlying security financial

"underlying_security_title: Common Shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did TerrAscend (TSNDF) report for its CFO?

TerrAscend reported a grant of stock options to its CFO covering 300,000 common shares. The options were awarded at a $0.76 exercise price, vest over four years, and expire in 2036, structuring his compensation around long-term share performance.

How many TerrAscend (TSNDF) options did the CFO receive and at what price?

The CFO received options on 300,000 TerrAscend common shares at a $0.76 exercise price. This means he can buy shares at $0.76 once vested, potentially benefiting if the market price exceeds that level in the future.

When do the TerrAscend (TSNDF) options granted to the CFO vest?

The granted options vest in four equal annual installments starting on the first anniversary of the grant date. This staggered vesting encourages the CFO to remain with TerrAscend and focus on the company’s longer-term operational and financial performance.

When do the CFO’s new TerrAscend (TSNDF) stock options expire?

The stock options granted to the CFO expire on April 27, 2036. After that expiration date, any unexercised options become worthless, so potential value depends on both vesting and future share prices before that deadline.

How many TerrAscend (TSNDF) derivative securities does the CFO hold after this grant?

After this grant, the CFO holds 300,000 derivative securities in the form of stock options. These options, once vested and exercised, would convert into 300,000 TerrAscend common shares at the fixed $0.76 exercise price per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/28/2026 - 06:05 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jackson Eric Matthew

(Last) (First) (Middle)

C/O TERRASCEND CORP.

77 CITY CENTRE DRIVE, SUITE 501

(Street)

MISSISSAUGA ONTARIO L5B 1M5

(City) (State) (Zip)

CANADA (FEDERAL LEVEL)

(Country)

2. Issuer Name and Ticker or Trading Symbol
TerrAscend Corp. [ TSNDF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$0.76	04/27/2026		A		300,000		(1)	04/27/2036	Common Shares	300,000	$0	300,000	D

Explanation of Responses:

1. The option vests in four equal annual installments beginning on the first anniversary of the grant date.

	/s/ Michelle Nelson, Attorney-in-Fact	04/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)